Cardan Capital Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $3.63M | Sell |
12,809
-89
| -0.7% | -$25.2K | 0.41% | 75 |
|
|
2021
Q2 | $4.47M | Sell |
12,898
-257
| -2% | -$89K | 0.5% | 64 |
|
|
2021
Q1 | $3.68M | Buy |
13,155
+286
| +2% | +$80K | 0.44% | 70 |
|
|
2020
Q4 | $3.15M | Sell |
12,869
-61
| -0.5% | -$14.9K | 0.39% | 78 |
|
|
2020
Q3 | $3.67M | Buy |
12,930
+607
| +5% | +$172K | 0.49% | 68 |
|
|
2020
Q2 | $3.3M | Buy |
12,323
+43
| +0.4% | +$11.5K | 0.47% | 74 |
|
|
2020
Q1 | $3.89M | Sell |
12,280
-277
| -2% | -$87.6K | 0.65% | 42 |
|
|
2019
Q4 | $3.73M | Buy |
12,557
+273
| +2% | +$81K | 0.5% | 57 |
|
|
2019
Q3 | $2.86M | Buy |
12,284
+551
| +5% | +$128K | 0.41% | 66 |
|
|
2019
Q2 | $2.74M | Buy |
11,733
+425
| +4% | +$99.4K | 0.42% | 66 |
|
|
2019
Q1 | $2.67M | Sell |
11,308
-58
| -0.5% | -$13.7K | 0.43% | 64 |
|
|
2018
Q4 | $3.42M | Sell |
11,366
-51
| -0.4% | -$15.3K | 0.6% | 49 |
|
|
2018
Q3 | $4.03M | Sell |
11,417
-95
| -0.8% | -$33.6K | 0.63% | 44 |
|
|
2018
Q2 | $3.34M | Buy |
11,512
+11
| +0.1% | +$3.19K | 0.55% | 51 |
|
|
2018
Q1 | $3.15M | Buy |
11,501
+45
| +0.4% | +$12.3K | 0.52% | 53 |
|
|
2017
Q4 | $3.65M | Sell |
11,456
-30
| -0.3% | -$9.56K | 0.69% | 47 |
|
|
2017
Q3 | $3.6M | Buy |
11,486
+43
| +0.4% | +$13.5K | 0.72% | 46 |
|
|
2017
Q2 | $3.11M | Sell |
11,443
-285
| -2% | -$77.3K | 0.6% | 51 |
|
|
2017
Q1 | $3.21M | Sell |
11,728
-25
| -0.2% | -$6.84K | 0.67% | 44 |
|
|
2016
Q4 | $3.33M | Sell |
11,753
-108
| -0.9% | -$30.6K | 0.74% | 44 |
|
|
2016
Q3 | $3.71M | Sell |
11,861
-179
| -1% | -$56K | 0.83% | 42 |
|
|
2016
Q2 | $2.91M | Buy |
12,040
+2
| +0% | +$484 | 0.72% | 43 |
|
|
2016
Q1 | $3.13M | Buy |
12,038
+4,180
| +53% | +$1.09M | 0.78% | 44 |
|
|
2015
Q4 | $2.41M | Buy |
+7,858
| New | +$2.41M | 1.03% | 33 |
|